VITA 34 AG (V3V.DE)
4.08
-0.08 (-1.92%)
At close: Mar 24, 2025, 4:36 PM
-1.92% (1D)
| Bid | n/a |
| Market Cap | 71.12M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | 0.17 |
| PE Ratio (ttm) | 24 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 41 |
| Avg. Volume (20D) | 1,073 |
| Open | 4.04 |
| Previous Close | 4.16 |
| Day's Range | 4.04 - 4.10 |
| 52-Week Range | 3.90 - 5.90 |
| Beta | 0.60 |
About V3V.DE
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; ...
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Mar 27, 2007
Employees 783
Stock Exchange XETRA
Ticker Symbol V3V.DE
Website https://www.vita34.de